Suppr超能文献

水通道蛋白参与人脑桥中央髓鞘溶解的证据。

Evidence of aquaporin involvement in human central pontine myelinolysis.

机构信息

Department Anatomy and Cell Biology, University of Saskatchewan, Saskatoon, SK, Canada.

出版信息

Acta Neuropathol Commun. 2013 Jul 25;1:40. doi: 10.1186/2051-5960-1-40.

Abstract

BACKGROUND

Central pontine myelinolysis (CPM) is a demyelinating disorder of the central basis pontis that is often associated with osmotic stress. The aquaporin water channels (AQPs) have been pathogenically implicated because serum osmolarity changes redistribute water and osmolytes among various central nervous system compartments.

RESULTS

We characterized the immunoreactivity of aquaporin-1 and aquaporin-4 (AQP1 and AQP4) and associated neuropathology in microscopic transverse sections from archival autopsied pontine tissue from 6 patients with pathologically confirmed CPM. Loss of both AQP1 and AQP4 was evident within demyelinating lesions in four of the six cases, despite the presence of glial fibrillary acidic protein (GFAP)-positive astrocytes. Lesional astrocytes were small, and exhibited fewer and shorter processes than perilesional astrocytes. In two of the six cases, astrocytes within demyelinating lesions exhibited increased AQP1 and AQP4 immunoreactivities, and gemistocytes and mitotic astrocytes were numerous. Blinded review of medical records revealed that all four cases lacking lesional AQP1 and AQP4 immunoreactivities were male, whereas the two cases with enhanced lesional AQP1 and AQP4 immunoreactivities were female.

CONCLUSIONS

This report is the first to establish astrocytic AQP loss in a subset of human CPM cases and suggests AQP1 and AQP4 may be involved in the pathogenesis of CPM. Further studies are required to determine whether the loss of AQP1 and AQP4 is restricted to male CPM patients, or rather may be a feature associated with specific underlying precipitants of CPM that may be more common among men. Non-rodent experimental models are needed to better clarify the complex and dynamic mechanisms involved in the regulation of AQPs in CPM, in order to determine whether it occurs secondary to the destructive disease process, or represents a compensatory mechanism protecting the astrocyte against apoptosis.

摘要

背景

桥脑中央髓鞘溶解症(CPM)是一种桥脑中央基底部的脱髓鞘疾病,常与渗透性应激有关。水通道蛋白(AQPs)已被认为是致病因素,因为血清渗透压的变化会在各种中枢神经系统隔室之间重新分配水和渗透物。

结果

我们对 6 例经病理证实的 CPM 存档尸检桥脑组织的微观横切片中的水通道蛋白-1 和水通道蛋白-4(AQP1 和 AQP4)的免疫反应性及其相关神经病理学进行了特征描述。在 6 例中的 4 例中,尽管存在胶质纤维酸性蛋白(GFAP)阳性星形胶质细胞,但脱髓鞘病变中明显缺失 AQP1 和 AQP4。病变星形胶质细胞较小,突起较病变周围星形胶质细胞短且少。在 6 例中的 2 例中,脱髓鞘病变内的星形胶质细胞表现出增强的 AQP1 和 AQP4 免疫反应性,并且有 Gemistocytes 和有丝分裂星形胶质细胞。对病历的盲法回顾显示,4 例缺乏病变 AQP1 和 AQP4 免疫反应性的病例均为男性,而 2 例病变 AQP1 和 AQP4 免疫反应性增强的病例为女性。

结论

本报告首次在人类 CPM 病例的亚组中确立了星形胶质细胞 AQP 的丢失,并表明 AQP1 和 AQP4 可能参与了 CPM 的发病机制。需要进一步的研究来确定 AQP1 和 AQP4 的丢失是否仅限于男性 CPM 患者,或者更可能是与 CPM 特定潜在诱发因素相关的特征,而这些因素在男性中更为常见。需要非啮齿类实验模型来更好地阐明 CPM 中 AQP 调节的复杂和动态机制,以确定其是否是继发于破坏性疾病过程,还是代表一种保护星形胶质细胞免于凋亡的代偿机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a75/3893459/775ff397e12c/2051-5960-1-40-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验